April 12, 2007 - In the first published nationwide survey of state Medicaid programs on "pay-for-performance" practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care. Almost 85 percent of states plan to have pay-for-performance programs within five years. Researchers also found that most current programs focus on women's, children's and adolescents' health issues. The study is published today by The Commonwealth Fund, a private foundation working toward a high-performance health system.

April 12, 2007 - In another study by Norwegian researchers, CAD showed the potential to increase the cancer detection rate for FFDM and for screen-film mammography in breast cancer screening performed with independent double reading.

April 12, 2007 - Merge Healthcare, a medical imaging software and services provider, announced that it will showcase its recently-released Merge Mammo version 7.0, multi-modality, vendor-neutral digital mammography workstation applications, at the 8th Postgraduate Course of the Society of Breast Imaging, April 14-17, 2007 in Hollywood, Florida.

April 12, 2007 - Suros Surgical Systems, Inc. a subsidiary of women's imaging group, Hologic, Inc.announced today the commercial launch of the Suros Celero,the first U.S. FDA-cleared spring loaded, vacuum assisted core biopsy device for the breast ultrasound market.

April 12, 2007 – Toshiba America Medical Systems Inc.’s Aquilion beta 256, a scanner that is reportedly able to measure subtle changes in blood flow or minute blockages forming in blood vessels no bigger than the average width of a toothpick in the heart and brain, was recently installed at a U.S. university medical center for three months of safety and clinical testing.

April 12, 2007 - Engineers at the Johns Hopkins Urology Robotics Lab recently reported the invention of its PneuStep, an MRI-safe motor that does not require the use of metal or electricity and can safely power remote-controlled robotic medical devices used for cancer biopsies and therapies guided by magnetic resonance imaging.

LifeVest, the first wearable defibrillator, protects people who have a high risk of sudden death, a common occurrence in patients with myocardial infarction and nonischemic cardiomyopathy.

CardioVive DM is reportedly a professional-grade AED with manual override and ECG monitoring.

It features automated voice prompts for the layperson while allowing physicians to switch from AED to manual defibrillation. Patented-powerful algorithms and variable escalating energy delivers the right amount of energy to the individual patient, said the company. The system also has optional 3-lead continuous ECG patient monitoring.

A lightweight patient monitor, the ARGUS PRO LifeCare is made to be used in emergency care, inter-hospital or in-house patient transfer.

The compact 2.1 kg package covers full diagnostic ECG, NIBP, SpO2 with plethysmogram and EtCO2 with capnogram, according to the company. It includes two temperatures, two invasive blood pressures, a defibrillator with AED and MANUAL mode and a transcutaneous pacemaker.

The AED 10 and AED 20 both feature a reportedly intuitive design to guide virtually any rescuer through a cardiac emergency. Using text messages, voice prompts and instructional illustrations, the AEDs automatically determine if a life-saving shock is required, yet protect against inappropriate delivery of electrical current to the patient. Intended for easy operation and quick deployment, the AED 10 and AED 20 use the simple “1-2-3” rescue approach.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now